Life Sciences Archives - Page 16 of 21 - Becker's Hospital Review

Eli Lilly sues spas, clinics over Mounjaro copycat | 3 biotech co. layoffs | J&J rebrands, cuts script logo | How Ascension is paring down amid $3B loss | Ozempic, Wegovy shortages could last years

September 20, 2023 BHR Newsletter 1. Eli Lilly sues spas, clinics over Mounjaro copycats Full story 2. How Ascension is paring down amid $3B loss Full story 3. 3 biotech company layoffs Full story 4. EHR training doesn't have to be a necessary evil. See how Froedtert…

2seventy bio cuts 40% of workforce | Ozempic, Wegovy tested as dementia, addiction drug | Aktiv Pharma Group to shutter operations | The healthcare quality blindspot | 5 updates on Mark Cuban's drug co.

September 13, 2023 BHR Newsletter 1. Biotech company cuts 40% of workforce Full story 2. A blind spot in healthcare quality work Full story 3. Ozempic, Wegovy enter trials for treating addiction, dementia Full story 4. A flexible workforce doesn't require reliance on contract labor. Hospitals are…

Absci lays off 15% of staff | Walgreens CEO steps down | Drugmaker recalls heart drug after dose mix-up | When C-level roles are too big for one person | 1st drug reduces 'sticky' cholesterol by 65%

September 6, 2023 BHR Newsletter 1. Biotech company lays off 15% of staff Full story 2. When C-level roles are too big for one person Full story 3. Walgreens CEO steps down Full story 4. OR improvement efforts are futile without surgeon buy-in. See how this hospital…

CVS launches biosimilar subsidiary | Pfizer eyes reopening NC plant | Fla. hospitals prep for Idalia | Rite Aid to file for bankruptcy | QuantHealth raises $15M | HHS invest $1.4B in new COVID-19 tools

August 30, 2023 BHR Newsletter 1. Pfizer eyes reopening North Carolina plant by Q4 Full story 2. 4 Florida hospitals evacuate, close ahead of Idalia Full story 3. Rite Aid to file for bankruptcy: Report Full story 4. Boost productivity — without the burnout. Register here to…

FDA halts Gilead cancer drug study | Willow taps new biopharma partner | Optum lays off nurses | 10 drugs CMS might tap for negotiations | FDA warns AstraZeneca over false advertising of COPD drug

August 23, 2023 BHR Newsletter 1. FDA pauses enrollment in Gilead cancer drug study Full story 2. All nurses reportedly laid off at more than 100 Optum-owned clinics Full story 3. The 10 drugs that CMS might wrangle into negotiations Full story 4. What's ChatGPT's place in…

FDA halts drug trial after subject's death | Drug co. cuts COO role, to lay off 400 | Top 10 universities for life sciences | Healthcare's widest CEO-worker pay gaps | Novo Nordisk to buy obesity drugmaker for $1B

August 16, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts • MyBHC 1. FDA puts drug trial on hold after subject's death Full story 2. 'It's ridiculous': Why hospitals pay millions to get paid electronically Full story 3. Maryland drug company cuts COO…

Ozempic, Mounjaro stomach paralysis claims led to lawsuit | Amazon zeros in on genomics | Ill. system lays off 20% of leaders | Sage considers job cuts, drug pricing delays

August 9, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts • MyBHC 1. Ozempic, Mounjaro drugmakers sued over stomach paralysis claims Full story 2. Illinois system lays off 20% of leadership Full story 3. Sage ponders cutting jobs, delaying drug pricing after partial…

Biogen to spend $7.3B on rare disease drugmaker | CVS Health to cut 5,000 jobs | FDA approves GSK cancer drug | Mich. hospital to close | Pfizer laying off 69 in Ill.

August 2, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts • MyBHC 1. Biogen to buy rare disease drugmaker for $7.3B Full story 2. Michigan hospital to close Full story 3. CVS Health to cut 5,000 jobs Full story 4. Innovation at breakneck speed is…

Biogen to cut 1,000 jobs | Drug shortages may worsen after tornado hit Pfizer plant | Cancer drug shortages threaten clinical trials | CHS to sell 3 hospitals | 5 Ozempic updates

July 26, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts • MyBHC 1. Biogen to cut 1,000 jobs Full story 2. CHS to sell 3 hospitals to Tampa General Full story 3. 66 drugs at risk of new, worsened shortages after tornado hit…

Eli Lilly to spend $1.93B on weight loss drugmaker | J&J must pay $19M to cancer patient | Mayo Clinic taps biotech innovation hub leaders | Cost Plus Drugs could hit hospitals by fall | Nurses protest name of Mo. hospital

July 19, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts • MyBHC 1. Eli Lilly to buy weight loss drugmaker for $1.93B Full story 2. Most socially responsible hospital in each state: Lown Institute Full story 3. Jury rules J&J must pay nearly…